Risk Assessment Score and Chi-Square Automatic Interaction Detection Algorithm for Hypertension Among Africans: Models From the SIREN Study.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
Dec 2023
Historique:
pmc-release: 01 12 2024
medline: 17 11 2023
pubmed: 13 10 2023
entrez: 13 10 2023
Statut: ppublish

Résumé

This study aimed to develop a risk-scoring model for hypertension among Africans. In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. Logistic regression models were applied to 13 risk factors. We randomly split the dataset into training and testing data at a ratio of 80:20. Constant and standardized weights were assigned to factors significantly associated with hypertension in the regression model to develop a probability risk score on a scale of 0 to 1 using a logistic regression model. The model accuracy was assessed to estimate the cutoff score for discriminating hypertensives. Mean age was 59.9±13.3 years, 56.0% were hypertensives, and 8 factors, including diabetes, age ≥65 years, higher waist circumference, (BMI) ≥30 kg/m The novel risk-scoring model discriminated hypertensives with good accuracy and will be helpful in the early identification of community-based Africans vulnerable to hypertension for its primary prevention.

Sections du résumé

BACKGROUND UNASSIGNED
This study aimed to develop a risk-scoring model for hypertension among Africans.
METHODS UNASSIGNED
In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. Logistic regression models were applied to 13 risk factors. We randomly split the dataset into training and testing data at a ratio of 80:20. Constant and standardized weights were assigned to factors significantly associated with hypertension in the regression model to develop a probability risk score on a scale of 0 to 1 using a logistic regression model. The model accuracy was assessed to estimate the cutoff score for discriminating hypertensives.
RESULTS UNASSIGNED
Mean age was 59.9±13.3 years, 56.0% were hypertensives, and 8 factors, including diabetes, age ≥65 years, higher waist circumference, (BMI) ≥30 kg/m
CONCLUSIONS UNASSIGNED
The novel risk-scoring model discriminated hypertensives with good accuracy and will be helpful in the early identification of community-based Africans vulnerable to hypertension for its primary prevention.

Identifiants

pubmed: 37830199
doi: 10.1161/HYPERTENSIONAHA.122.20572
pmc: PMC10715722
mid: NIHMS1934924
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2581-2590

Subventions

Organisme : NHGRI NIH HHS
ID : U24 HG009780
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW012030
Pays : United States
Organisme : NHLBI NIH HHS
ID : UE5 HL172183
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS115944
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107900
Pays : United States
Organisme : NINDS NIH HHS
ID : R13 NS115395
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS114045
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG007479
Pays : United States

Références

Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
J Hum Hypertens. 2021 Jan;35(1):74-84
pubmed: 32107452
J Stroke Cerebrovasc Dis. 2021 Oct;30(10):106003
pubmed: 34332227
BMC Public Health. 2017 Jan 11;17(1):64
pubmed: 28077112
Stroke. 2016 Jan;47(1):167-72
pubmed: 26578660
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
J Clin Hypertens (Greenwich). 2021 Apr;23(4):773-784
pubmed: 33484599
eNeurologicalSci. 2016 Jun;3:75-79
pubmed: 27148595
Asia Pac J Public Health. 2016 Jan;28(1 Suppl):26S-31S
pubmed: 26354334
J Clin Hypertens (Greenwich). 2010 Oct;12(10):800-8
pubmed: 21029343
Hypertension. 2013 Feb;61(2):319-26
pubmed: 23232644
J Clin Hypertens (Greenwich). 2013 May;15(5):344-9
pubmed: 23614850
Sci Rep. 2020 Jun 30;10(1):10620
pubmed: 32606434
Hypertension. 2017 Mar;69(3):421-427
pubmed: 28137988
BMC Nephrol. 2014 Mar 06;15:42
pubmed: 24602391
Lancet Glob Health. 2018 Apr;6(4):e436-e446
pubmed: 29496511
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Jun;27(6):540-3
pubmed: 17152519
J Neurol Sci. 2011 Jul 15;306(1-2):108-14
pubmed: 21489563
Lancet. 2012 Jul 21;380(9838):192-3
pubmed: 22818933
J Clin Hypertens (Greenwich). 2018 May;20(5):880-890
pubmed: 29604170
Hypertension. 2009 Sep;54(3):496-501
pubmed: 19597041
Di Yi Jun Yi Da Xue Xue Bao. 2003 Dec;23(12):1352-4
pubmed: 14678913
Int J Med Sci. 2019 Jun 2;16(6):793-799
pubmed: 31337952
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
Am J Geriatr Psychiatry. 2013 Oct;21(10):957-62
pubmed: 23567433
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
J Hum Hypertens. 2011 May;25(5):294-303
pubmed: 20613783
Hypertension. 2020 May;75(5):1167-1178
pubmed: 32172619
J Clin Hypertens (Greenwich). 2020 Mar;22(3):445-450
pubmed: 31816148
Ann Behav Med. 2003 Dec;26(3):172-81
pubmed: 14644693
Clin Chim Acta. 2008 Aug;394(1-2):1-6
pubmed: 18455512
J Infect. 2016 Feb;72(2):143-51
pubmed: 26702737
Artif Intell Med. 2009 Jan;45(1):1-10
pubmed: 19091533
BMC Cardiovasc Disord. 2019 Jul 22;19(1):173
pubmed: 31331284
Sci Rep. 2021 Feb 25;11(1):4716
pubmed: 33633182
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
Hypertension. 2010 Apr;55(4):1058-62
pubmed: 20157053
Cancer Causes Control. 2002 Nov;13(9):813-23
pubmed: 12462546
Environ Res. 2014 Jul;132:190-6
pubmed: 24792416
J Hypertens. 2011 Aug;29(8):1486-93
pubmed: 21720268
Ann Intern Med. 2008 Jan 15;148(2):102-10
pubmed: 18195335
Medicine (Baltimore). 2017 Feb;96(6):e6090
pubmed: 28178169
Anadolu Kardiyol Derg. 2007 Jun;7(2):140-5
pubmed: 17513208
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Disabil Rehabil. 2006 Mar 15;28(5):257-70
pubmed: 16492620
J Hypertens. 2022 May 1;40(5):1010-1018
pubmed: 35153282
Neuroepidemiology. 2015;45(2):73-82
pubmed: 26304844
BMJ Open. 2021 Jul 7;11(7):e048734
pubmed: 34233994
Indian J Public Health. 2005 Oct-Dec;49(4):218-22
pubmed: 16479901
J Cardiovasc Dis Res. 2012 Apr;3(2):117-23
pubmed: 22629029
Acad Pediatr. 2018 Jan - Feb;18(1):43-50
pubmed: 28723587
Acad Emerg Med. 2019 May;26(5):517-527
pubmed: 30659702
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
Am J Cardiol. 1999 Feb 1;83(3):371-5
pubmed: 10072226
Am J Med. 2009 May;122(5):464-71
pubmed: 19375556
Am J Prev Med. 1990;6(2 Suppl):23-8
pubmed: 2383409
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272

Auteurs

Osahon J Asowata (OJ)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Akinkunmi Paul Okekunle (AP)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).
Seoul National University, Korea (A.O.).

Onoja M Akpa (OM)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Adekunle Gregory Fakunle (AG)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).
College of Health Sciences, Osun State University, Osogbo, Nigeria (A.G.F.).

Joshua O Akinyemi (JO)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Morenikeji Adeyoyin Komolafe (MA)

Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria (M.A.K.).

Fred Stephen Sarfo (FS)

Kwame Nkrumah University of Science and Technology, Ghana (F.S.S., A.T.L., A.S.).

Albert K Akpalu (AK)

University of Ghana Medical School, Accra (A.K.A., B.N.L.C.-T., Y.B.M., R.Y.L.).

Reginald Obiako (R)

Ahmadu Bello University, Zaria, Nigeria (R.O., P.O.I., O.B.).

Kolawole W Wahab (KW)

University of Ilorin Teaching Hospital, Nigeria (K.W.W., S.A.A.).

Godwin O Osaigbovo Osawaru (GO)

Jos University Teaching Hospital Jos, Nigeria (G.O.O.).

Lukman F Owolabi (LF)

Aminu Kano Teaching Hospital, Kano, Nigeria (L.F.O.).

Carolyn M Jenkins (CM)

Medical University of South Carolina (C.M.J.).

Benedict Nii Laryea Calys-Tagoe (BNL)

University of Ghana Medical School, Accra (A.K.A., B.N.L.C.-T., Y.B.M., R.Y.L.).

Oyedunni Sola Arulogun (OS)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Godwin I Ogbole (GI)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Okechukwu Samuel Ogah (OS)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).

Appiah T Lambert (AT)

Kwame Nkrumah University of Science and Technology, Ghana (F.S.S., A.T.L., A.S.).

Philip Oluleke Ibinaiye (PO)

Ahmadu Bello University, Zaria, Nigeria (R.O., P.O.I., O.B.).

Philip B Adebayo (PB)

Aga-Khan University Dar es Salaam, Tanzania (P.B.A.).

Arti Singh (A)

Kwame Nkrumah University of Science and Technology, Ghana (F.S.S., A.T.L., A.S.).

Sunday Adebori Adeniyi (SA)

University of Ilorin Teaching Hospital, Nigeria (K.W.W., S.A.A.).

Yaw B Mensah (YB)

University of Ghana Medical School, Accra (A.K.A., B.N.L.C.-T., Y.B.M., R.Y.L.).

Ruth Y Laryea (RY)

University of Ghana Medical School, Accra (A.K.A., B.N.L.C.-T., Y.B.M., R.Y.L.).

Olayemi Balogun (O)

Ahmadu Bello University, Zaria, Nigeria (R.O., P.O.I., O.B.).

Innocent Ijezie Chukwuonye (II)

Federal Medical Centre, Umuahia, Nigeria (I.I.C.).

Rufus O Akinyemi (RO)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).
Federal Medical Centre, Abeokuta, Nigeria (R.O.A.).

Bruce Ovbiagele (B)

Weill Institute for Neurosciences, University of California San Francisco (B.O.).

Mayowa Ojo Owolabi (MO)

University of Ibadan, Nigeria (O.J.A., A.P.O., O.M.A, A.G.F., J.O.A., O.S.A, G.I.O., O.S.O., R.O.A., M.O.O.).
Lebanese American University, Beirut (M.O.O.).
University College Hospital, Ibadan, Nigeria (M.O.O.).
Blossom Specialist Medical Center, Ibadan, Nigeria (M.O.O.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH